Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Trumpfheller

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal for Immunotherapy of Cancer|June 10, 2022
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cellsMi He, Bhavesh Soni, Petra C Schwalie, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2011
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primatesBarbara J Flynn, Kathrin Kastenmüller, Ulrike Wille-Reece, et al.
The Journal of Experimental Medicine|November 9, 2011
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humansMarina Caskey, François Lefebvre, Abdelali Filali-Mouhim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor ImmunityEva Sum, Moritz Rapp, Philipp Fröbel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
FAP-Targeted LTBR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid TumoursRoberta Bianchi, Leo Kunz, Ralf J Hosse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2022
Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8<sup>+</sup> T Cell Responses with Antitumor ActivityMatthew G Booty, Kelan A Hlavaty, Adam Stockmann, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal for Immunotherapy of Cancer|June 10, 2022
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cellsMi He, Bhavesh Soni, Petra C Schwalie, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2011
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primatesBarbara J Flynn, Kathrin Kastenmüller, Ulrike Wille-Reece, et al.
The Journal of Experimental Medicine|November 9, 2011
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humansMarina Caskey, François Lefebvre, Abdelali Filali-Mouhim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor ImmunityEva Sum, Moritz Rapp, Philipp Fröbel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
FAP-Targeted LTBR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid TumoursRoberta Bianchi, Leo Kunz, Ralf J Hosse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2022
Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8<sup>+</sup> T Cell Responses with Antitumor ActivityMatthew G Booty, Kelan A Hlavaty, Adam Stockmann, et al.
Pageof 4